We use this note to address some concerns weighing on investor sentiment post the AGM update. We conclude these are overplayed and detract from the excellent work done by management to position CVS for sustained value accretion. The 15% de-rating is overdone on fundamental analysis and relative to major sector deals. Overall, we see the current share price weakness as a rare buying opportunity.
11 Dec 2017
N+1 Singer - CVS Group - Still top pedigree
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - CVS Group - Still top pedigree
CVS Group plc (CVSG:LON) | 952 9.5 0.1% | Mkt Cap: 683.1m
- Published:
11 Dec 2017 -
Author:
Sahill Shan -
Pages:
13
We use this note to address some concerns weighing on investor sentiment post the AGM update. We conclude these are overplayed and detract from the excellent work done by management to position CVS for sustained value accretion. The 15% de-rating is overdone on fundamental analysis and relative to major sector deals. Overall, we see the current share price weakness as a rare buying opportunity.